Clinical investigators at Georgetown University are seeking to advance precision medicine techniques for the prognosis and treatment of brain tumors through the identification of novel multi-omics biomarkers.

In support of this goal, precisionFDA, the Georgetown Lombardi Comprehensive Cancer Center, and the Innovation Center for Biomedical Informatics at Georgetown University Medical Center (Georgetown-ICBI) are launching the Brain Cancer Predictive Modeling and Biomarker Discovery Challenge on November 1, 2019. This challenge will ask participants to develop machine learning and/or artificial intelligence models to identify biomarkers and predict patient outcomes using clinical, DNA copy number, and gene expression data. Learn more about the challenge and pre-register.